Sumitomo Mitsui Trust Group Inc. Sells 21,337 Shares of Alexandria Real Estate Equities, Inc. $ARE

Sumitomo Mitsui Trust Group Inc. lessened its position in Alexandria Real Estate Equities, Inc. (NYSE:ARE) by 1.8% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,162,474 shares of the real estate investment trust’s stock after selling 21,337 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Alexandria Real Estate Equities were worth $96,881,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in ARE. Norges Bank purchased a new position in Alexandria Real Estate Equities during the second quarter valued at $1,195,306,000. State Street Corp increased its stake in shares of Alexandria Real Estate Equities by 1.7% in the 2nd quarter. State Street Corp now owns 10,873,745 shares of the real estate investment trust’s stock worth $803,863,000 after acquiring an additional 181,674 shares in the last quarter. Geode Capital Management LLC lifted its position in Alexandria Real Estate Equities by 1.9% during the 2nd quarter. Geode Capital Management LLC now owns 4,318,035 shares of the real estate investment trust’s stock valued at $312,407,000 after acquiring an additional 82,591 shares during the period. Invesco Ltd. boosted its stake in Alexandria Real Estate Equities by 16.8% during the second quarter. Invesco Ltd. now owns 3,676,318 shares of the real estate investment trust’s stock worth $267,011,000 after acquiring an additional 528,575 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. grew its holdings in Alexandria Real Estate Equities by 4.9% in the second quarter. Charles Schwab Investment Management Inc. now owns 2,655,204 shares of the real estate investment trust’s stock worth $192,848,000 after purchasing an additional 125,020 shares during the period. Institutional investors own 96.54% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the stock. Morgan Stanley initiated coverage on shares of Alexandria Real Estate Equities in a report on Friday. They set an “equal weight” rating and a $55.00 target price for the company. BNP Paribas cut Alexandria Real Estate Equities from a “hold” rating to a “strong sell” rating and set a $82.00 price objective for the company. in a research note on Wednesday, October 1st. Deutsche Bank Aktiengesellschaft cut their target price on Alexandria Real Estate Equities from $83.00 to $45.00 and set a “hold” rating on the stock in a research note on Friday, December 19th. Evercore ISI reduced their price target on Alexandria Real Estate Equities from $72.00 to $64.00 and set an “outperform” rating for the company in a report on Thursday, December 4th. Finally, JPMorgan Chase & Co. dropped their price target on shares of Alexandria Real Estate Equities from $95.00 to $65.00 in a research note on Monday, November 3rd. Four analysts have rated the stock with a Buy rating, nine have issued a Hold rating and four have given a Sell rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $68.56.

Alexandria Real Estate Equities Stock Up 0.5%

Alexandria Real Estate Equities stock opened at $54.63 on Wednesday. Alexandria Real Estate Equities, Inc. has a 12 month low of $44.10 and a 12 month high of $105.14. The stock has a fifty day simple moving average of $50.40 and a two-hundred day simple moving average of $68.31. The company has a current ratio of 0.24, a quick ratio of 0.24 and a debt-to-equity ratio of 0.65. The firm has a market cap of $9.44 billion, a price-to-earnings ratio of -22.12, a PEG ratio of 6.53 and a beta of 1.31.

Alexandria Real Estate Equities (NYSE:ARE) last announced its quarterly earnings results on Monday, October 27th. The real estate investment trust reported $2.22 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.31 by ($0.09). Alexandria Real Estate Equities had a negative net margin of 13.43% and a negative return on equity of 1.89%. The business had revenue of $751.94 million for the quarter, compared to the consensus estimate of $752.90 million. During the same period in the previous year, the company earned $2.37 earnings per share. The company’s revenue for the quarter was down 5.0% compared to the same quarter last year. Alexandria Real Estate Equities has set its FY 2025 guidance at 8.980-9.040 EPS. Equities analysts predict that Alexandria Real Estate Equities, Inc. will post 9.32 EPS for the current fiscal year.

Alexandria Real Estate Equities Cuts Dividend

The business also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be issued a $0.72 dividend. The ex-dividend date is Wednesday, December 31st. This represents a $2.88 annualized dividend and a yield of 5.3%. Alexandria Real Estate Equities’s dividend payout ratio (DPR) is currently -116.60%.

Alexandria Real Estate Equities declared that its Board of Directors has initiated a stock repurchase program on Monday, December 8th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the real estate investment trust to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company’s board believes its stock is undervalued.

More Alexandria Real Estate Equities News

Here are the key news stories impacting Alexandria Real Estate Equities this week:

• Positive Sentiment: Promotion and pay changes that may help retain management and align incentives — Alexandria amended Executive Chairman Joel’s package and boosted performance‑based pay while promoting a co‑president, signaling a management retention/governance move that some investors view as constructive. Article Title
• Neutral Sentiment: Elevated short interest — Short interest rose ~31% in December to about 9.09M shares (~5.3% of shares outstanding) with a days‑to‑cover near 3.5. This increases the potential for headline‑driven volatility (both downside pressure and squeeze dynamics) but does not by itself change fundamentals.
• Negative Sentiment: Impairment charge and sharp stock drop prompted multiple class‑action lawsuits — A large impairment charge in early January triggered a roughly 19% stock decline and led to several securities‑fraud suits and law‑firm solicitations alleging misstatements. These legal actions can create headline risk, potential legal costs, and management distraction. Article Title
• Negative Sentiment: Multiple law firms soliciting lead plaintiffs ahead of Jan 26 deadline — Several firms (BFA, Faruqi & Faruqi, Rosen, Pomerantz, Glancy, Bragar, et al.) have publicized claims and deadlines, increasing the likelihood of consolidated litigation and potential damages/settlement exposure. Investors should watch filings and developments. Faruqi Notice Rosen Notice

Insiders Place Their Bets

In related news, Director Sheila K. Mcgrath bought 3,100 shares of the firm’s stock in a transaction on Wednesday, December 10th. The stock was acquired at an average cost of $45.60 per share, for a total transaction of $141,360.00. Following the purchase, the director owned 8,392 shares in the company, valued at approximately $382,675.20. This represents a 58.58% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 1.15% of the company’s stock.

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc (NYSE: ARE) is a real estate investment trust specializing in the ownership, development and management of collaborative life science and technology campuses. The company’s properties are designed to support research and innovation by providing specialized laboratory, office and manufacturing space tailored to biotechnology, pharmaceutical, academic and related industries.

Since its founding in 1994, Alexandria has cultivated a diversified portfolio of campuses across leading innovation clusters in North America and Europe.